ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,361, issued on July 1, was assigned to Labyrinth Holdings LLC (Sugar Land, Texas).

"Compositions and methods for the treatment of hepatic diseases and disorders" was invented by Elizabeth McKenna (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides oral compositions and methods of using such compositions in treating subjects infected with one or more hepatic disorders. The compositions include lysates or cell wall extracts of one or more gram positive bacteria, exhibit particular activity against hepatitis C virus (HCV), and may be useful in treating those infected with HCV as well as other hepatic diseases or disorders. Al...